Sarah TsouView Public Profile
Sarah Tsou is an Investment Manager and Legal Counsel for Omni Bridgeway leading the company’s intellectual property initiatives.
Prior to joining the company’s New York office in 2019, Sarah was a partner in the intellectual property practice group at Kirkland & Ellis LLP, focusing on patent litigation. In addition to handling patent disputes spanning a broad range of technologies and industries, she also led trade secret and trademark litigation teams and counseled clients in corporate acquisitions, licensing matters, and other transactions.
Sarah approaches litigation funding deal evaluation and diligence with the expertise of a litigator who has spent over a dozen years representing clients in all aspects of complex litigation from inception to trial. She has advised clients ranging from start-ups to Fortune 100 companies on risk, cost analysis, IP portfolio and market analysis, and strategy, and she understands the factors that companies and law firms weigh when deciding whether to engage in litigation. Her substantial case evaluation and trial experience informs her ability to structure funding deals that allow alignment of risk between all parties to the deal. Having secured significant verdicts and judgments for clients in industries including computer software, electronics, pharmaceuticals, medical devices, biotechnology, and oilfield services, she offers valuable insights to Omni Bridgeway’s funded clients and their counsel when they need strategic advice during the course of litigation.
Sessions with Sarah Tsou
03:00 PM EST
January 24, 2022
The PTAB as the First Hurdle to Patent Monetization: How Patent Owners and Litigation Financers Deal with this Omnipresent Threat
From increasing damage awards into the billions of dollars, to a new hot patent court for plaintiffs in West Texas, to increased financing available from litigation funders to growth in competitor lawsuits with large entities looking to monetize their own portfolios, there is a changing face of patent litigation as we head into a post-pandemic world. Of course, the PTAB…